Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB4754770,11
PKN37,837,98-2,28
Msft-1,10
Nokia2,89152,90652,75
IBM2,53
Daimler AG44,59544,6150,40
PFE0,57
31.10.2020 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 29.10.2020
Stentys SA, Ordinary, MiFID Eligible Security, Frankfurt Stock Exchange (STEN.PA, Paris)
Závěr k 29.10.2020 Změna (%) Změna (EUR) Objem obchodů (EUR)
0,416 0,00 0,00 24 757
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 31.10.2020
Popis společnosti
Obecné informace
Název společnostiStentys SAS
TickerSTNT
Kmenové akcie:Ordinary Shares
RICSTEN.PA
ISINFR0010949404
Poslední známé roční výsledky31.12.2018
Poslední známé čtvrtletní výsledky30.09.2019
Počet zaměstnanců k 31.12.2018 32
Akcie v oběhu k 01.07.2019 26 824 657
MěnaEUR
Kontaktní informace
Ulice18 Rue d'Hauteville
MěstoPARIS
PSČ75010
ZeměFrance
Kontatní osoba 
Funkce kontaktní osoby 
Telefon33 144 539 942
Fax33144539924

Business Summary: Stentys SA is a French-based company specialized in the development of a new generation of stents for the treatment of acute myocardial infarction or coronary artery disease. It's main product STENTYS Stent, self-expanding coronary bare-metal stent system, is indicated for the treatment of Acute Coronary Syndrome. The Company's institutional shareholders are Sofinnova Partners, Credit Agricole Private Equity and Scottish Equity Partners. In June 2014, it acquired Cappella Peel Away Inc.
Financial Summary: BRIEF: For the six months ended 30 June 2019, Stentys SAS revenues increased 40% to EUR5.1M. Net loss increased from EUR3.1M to EUR18.1M. Revenues reflect Other Products increase from EUR2K to EUR50K. Higher net loss reflects Sales & Marketing/Depreciation increase from EUR6K to EUR207K (expense), Other Research & Development increase of 88% to EUR242K (expense), R&D/Personnel Expenses increase of 16% to EUR382K (expense).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
SICSurgical And Medical Instruments



  • Poslední aktualizace: 31.10.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardMichel Darnaud-28.03.201328.03.2013
Administrative and Financial Director, Member of the Management BoardStanislas Piot-
Director of Operations and Member of the Management BoardBenoit Vandenbossche-
Vice President of Sales and Marketing and Member of the Management BoardLucien Goffart-
Research and Development and Production Manager, Member of the Management BoardHikmat Hojeibane-
Director of Regulatory Affairs and Quality and Member of the Management BoardLuc Morisset-
Chief Medical Officer and Member of the Management BoardRene Spaargaren-